Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
Canada
UBC Okanagan, Kelowna, British Columbia International Collaboration on Repair Discoveries (ICORD), Vancouver, British Columbia